Correlation Between Propanc Biopharma and Krystal Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Propanc Biopharma and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Propanc Biopharma and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Propanc Biopharma and Krystal Biotech, you can compare the effects of market volatilities on Propanc Biopharma and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Propanc Biopharma with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Propanc Biopharma and Krystal Biotech.

Diversification Opportunities for Propanc Biopharma and Krystal Biotech

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Propanc and Krystal is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Propanc Biopharma and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Propanc Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Propanc Biopharma are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Propanc Biopharma i.e., Propanc Biopharma and Krystal Biotech go up and down completely randomly.

Pair Corralation between Propanc Biopharma and Krystal Biotech

Given the investment horizon of 90 days Propanc Biopharma is expected to under-perform the Krystal Biotech. In addition to that, Propanc Biopharma is 3.47 times more volatile than Krystal Biotech. It trades about -0.07 of its total potential returns per unit of risk. Krystal Biotech is currently generating about 0.18 per unit of volatility. If you would invest  17,622  in Krystal Biotech on August 30, 2024 and sell it today you would earn a total of  2,069  from holding Krystal Biotech or generate 11.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Propanc Biopharma  vs.  Krystal Biotech

 Performance 
       Timeline  
Propanc Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Krystal Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Krystal Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Propanc Biopharma and Krystal Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Propanc Biopharma and Krystal Biotech

The main advantage of trading using opposite Propanc Biopharma and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Propanc Biopharma position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.
The idea behind Propanc Biopharma and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance